However, the plasmonic microarrays used in previous work, for the detection of bowel cancer biomarker, carcinoembryonic antigen (CEA) and three lung cancer biomarkers22,23, lacked systematic control of their nanoscale structure and the corresponding optical properties. This evidence concerns the gene CEACAM5 and lung cancer.